← Back to headlines
XORTX Therapeutics Reports Q2 GAAP EPS of -$1.05
XORTX Therapeutics Inc. announced its second-quarter financial results, reporting a GAAP Earnings Per Share (EPS) of -$1.05.
21 Aug, 20:22 — 21 Aug, 20:22
Sources
Showing 1 of 1 sources
